Coagulation management in multiple trauma: a systematic review
Authors:
- 12 February 2011
- journal article
- review article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 37 (4) , 572-582
Abstract
The management of trauma patients suffering from active bleeding has improved with a better understanding of trauma-induced coagulopathy. The aim of this manuscript is to give recommendations for coagulation management. A systematic literature search in the PubMed database was performed for articles published between January 2000 and August 2009. A total of 230 articles were included in the present systematic review. The "coagulopathy of trauma" is a discrete disease which has a decisive influence on survival. Diagnosis and therapy of deranged coagulation should start immediately after admission to the emergency department. A specific protocol for massive transfusion should be introduced and continued. Loss of body temperature should be prevented and treated. Acidaemia should be prevented and treated by appropriate shock therapy. If massive transfusion is performed using fresh frozen plasma (FFP), a ratio of FFP to pRBC (packed red blood cells) of 1:2-1:1 should be achieved. Fibrinogen should be substituted at levels of <1.5 g/L. For patients suffering from active bleeding, permissive hypotension (i.e. mean arterial pressure ~65 mmHg) may be aimed for until surgical cessation of bleeding. This option is contraindicated in injuries of the central nervous system and in patients with coronary heart disease, or with known hypertension. Thrombelastography or -metry may be performed to guide coagulation diagnosis and substitution. Hypocalcaemia <0.9 mmol/L should be avoided and may be treated. For actively bleeding patients, pRBC may be given at haemoglobin <10 g/L (6.2 mmol/L) and haematocrit may be targeted at 30%.Keywords
This publication has 89 references indexed in Scilit:
- Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trialThe Lancet, 2010
- Management of bleeding following major trauma: an updated European guidelineCritical Care, 2010
- The Efficacy of Recombinant Activated Factor VII in Severe TraumaAnnals of Emergency Medicine, 2009
- Resuscitation and transfusion principles for traumatic hemorrhagic shockBlood Reviews, 2009
- Transfusion Management of Trauma PatientsAnesthesia & Analgesia, 2009
- Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma modelBritish Journal of Anaesthesia, 2009
- The Relationship of Blood Product Ratio to Mortality: Survival Benefit or Survival Bias?Journal of Trauma: Injury, Infection & Critical Care, 2009
- Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysisBMJ, 2007
- Acute Traumatic Coagulopathy: Initiated by HypoperfusionAnnals of Surgery, 2007
- Colloids decrease clot propagation and strength: role of factor XIII‐fibrin polymer and thrombin–fibrinogen interactionsActa Anaesthesiologica Scandinavica, 2005